Skip to main content

Sculptor Capital LP

Position in NVAX — Novavax Inc

CIK 1054587 New York, NY

Position in NVAX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
13 quarters on record

Common Shares in NVAX Over Time

Shares Held

Position Value (USD)

Derivatives in NVAX

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$936,348
PutShares
99,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Sculptor Capital LP holds $32,206,136 across 10 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in NVAX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $936,348 99,400
2026-03-31 $809,116 99,400
2025-12-31 $5,884,032 875,600
2025-09-30 $7,591,452 875,600
2025-06-30 $5,223,960 829,200
2025-03-31 $5,286,327 824,700
2024-12-31 $1,608 200
2024-12-31 $6,319,440 786,000
2024-09-30 $9,711,207 768,900
2024-09-30 $2,526 200
2024-06-30 $2,532 200
2024-06-30 $2,532 200
2023-12-31 $160,800 33,500
2023-12-31 $160,800 33,500
2023-06-30 $604,059 81,300
2023-06-30 $604,059 81,300
2023-03-31 $5,230,764 754,800
2023-03-31 $2,101,176 303,200
2023-03-31 $3,974,355 573,500
2022-12-31 $5,895,580 573,500
2022-12-31 $5,895,580 573,500